Literature DB >> 22829139

Anti-inflammatory effect of 3,4-oxo-isopropylidene-shikimic acid on acetic acid-induced colitis in rats.

Jianfeng Xing1, Jinyao Sun, Haisheng You, Jun Lv, Jianning Sun, Yalin Dong.   

Abstract

The present work was done to investigate the possible effects of 3,4-oxo-isopropylidene-shikimic acid (ISA) on acetic acid (AA)-induced colitis in rats. Colitis was induced by intracolonic injection of 6 % AA. Several parameters, including macroscopic score and biochemical parameters, were determined to assess the degree of protection. Biochemical parameters such as myeloperoxidase (MPO) activity, malondialdehyde (MDA) and nitric oxide (NO) levels, and superoxide dismutase (SOD) and inducible NO synthase (NOS) activities were measured following standard assay procedures. The study showed that treatment of rats for 6 days with ISA (100 and 200 mg/kg) was able to give complete protection against AA-induced colitis. Moreover, biochemical changes were reversed and brought toward control. These results suggest a beneficial effect of ISA against experimental colitis and the possible mechanism of the protective effects may be partly due to an antioxidant action.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829139     DOI: 10.1007/s10753-012-9509-7

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

Review 1.  Emerging immunological targets in inflammatory bowel disease.

Authors:  Giovanni Monteleone; Francesco Pallone; Thomas T MacDonald
Journal:  Curr Opin Pharmacol       Date:  2011-10-12       Impact factor: 5.547

2.  Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.

Authors:  C Loguercio; G D'Argenio; M Delle Cave; V Cosenza; N Della Valle; G Mazzacca; C del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Inflammatory bowel disease--a radical view.

Authors:  N J Simmonds; D S Rampton
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

4.  Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells.

Authors:  Christy-Lynn M Cooke; Sandra T Davidge
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

5.  Antagonistic effects of shikimic acid against focal cerebral ischemia injury in rats subjected to middle cerebral artery thrombosis.

Authors:  Y Ma; Q P Xu; J N Sun; L M Bai; Y J Guo; J Z Niu
Journal:  Zhongguo Yao Li Xue Bao       Date:  1999-08

6.  Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities.

Authors:  Göksel Sener; Halil Aksoy; Ozer Sehirli; Meral Yüksel; Cenk Aral; Nursal Gedik; Sule Cetinel; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

7.  Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.

Authors:  A D Millar; D S Rampton; C L Chander; A W Claxson; S Blades; A Coumbe; J Panetta; C J Morris; D R Blake
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

8.  Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.

Authors:  Joaquim Seguí; Meritxell Gironella; Miquel Sans; Susana Granell; Fèlix Gil; Mercedes Gimeno; Pilar Coronel; Josep M Piqué; Julián Panés
Journal:  J Leukoc Biol       Date:  2004-06-14       Impact factor: 4.962

9.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

10.  Potential role of nitric oxide in a model of chronic colitis in rhesus macaques.

Authors:  K A Ribbons; X J Zhang; J H Thompson; S S Greenberg; W M Moore; C M Kornmeier; M G Currie; N Lerche; J Blanchard; D A Clark
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

View more
  6 in total

1.  Metabolite profiling of whiteleg shrimp Litopenaeus vannamei from super-intensive culture in closed aquaculture systems: a recirculating aquaculture system and a hybrid zero water discharge-recirculating aquaculture system.

Authors:  Gede Suantika; Magdalena Lenny Situmorang; Felicia Irene Saputra; Safira Latifa Erlangga Putri; Sastia Prama Putri; Pingkan Aditiawati; Eiichiro Fukusaki
Journal:  Metabolomics       Date:  2020-04-10       Impact factor: 4.290

2.  Extraction and Chromatographic Determination of Shikimic Acid in Chinese Conifer Needles with 1-Benzyl-3-methylimidazolium Bromide Ionic Liquid Aqueous Solutions.

Authors:  Fengli Chen; Kexin Hou; Shuangyang Li; Yuangang Zu; Lei Yang
Journal:  J Anal Methods Chem       Date:  2014-03-23       Impact factor: 2.193

Review 3.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

Review 4.  A review on chemical-induced inflammatory bowel disease models in rodents.

Authors:  Puneet Kaur Randhawa; Kavinder Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

5.  Antibacterial Activity of Shikimic Acid from Pine Needles of Cedrus deodara against Staphylococcus aureus through Damage to Cell Membrane.

Authors:  Jinrong Bai; Yanping Wu; Xiaoyan Liu; Kai Zhong; Yina Huang; Hong Gao
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

Review 6.  A Review on Ethnopharmacological Applications, Pharmacological Activities, and Bioactive Compounds of Mangifera indica (Mango).

Authors:  Meran Keshawa Ediriweera; Kamani Hemamala Tennekoon; Sameera Ranganath Samarakoon
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.